chr1-151722138-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144956.3(RIIAD1):āc.137A>Gā(p.Glu46Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,551,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001144956.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIIAD1 | NM_001144956.3 | c.137A>G | p.Glu46Gly | missense_variant | 2/5 | ENST00000479191.2 | NP_001138428.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIIAD1 | ENST00000479191.2 | c.137A>G | p.Glu46Gly | missense_variant | 2/5 | 2 | NM_001144956.3 | ENSP00000419249.1 | ||
RIIAD1 | ENST00000326413.7 | c.167A>G | p.Glu56Gly | missense_variant | 6/9 | 2 | ENSP00000420280.1 | |||
RIIAD1 | ENST00000426175.5 | n.10A>G | non_coding_transcript_exon_variant | 1/3 | 5 | |||||
RIIAD1 | ENST00000451484.6 | n.154A>G | non_coding_transcript_exon_variant | 2/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000909 AC: 14AN: 154096Hom.: 0 AF XY: 0.0000489 AC XY: 4AN XY: 81770
GnomAD4 exome AF: 0.0000164 AC: 23AN: 1398906Hom.: 0 Cov.: 29 AF XY: 0.0000116 AC XY: 8AN XY: 689994
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.137A>G (p.E46G) alteration is located in exon 2 (coding exon 2) of the RIIAD1 gene. This alteration results from a A to G substitution at nucleotide position 137, causing the glutamic acid (E) at amino acid position 46 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at